Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Joyner and Chad Wiggins.
Michael Joyner
Connection Strength
1.915
Chad Wiggins
  1. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
    View in: PubMed
    Score: 0.240
  2. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151.
    View in: PubMed
    Score: 0.237
  3. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 08; 61(8):2503-2511.
    View in: PubMed
    Score: 0.237
  4. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275.
    View in: PubMed
    Score: 0.232
  5. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19. Clin Microbiol Newsl. 2021 Feb 15; 43(4):23-32.
    View in: PubMed
    Score: 0.232
  6. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 03 18; 384(11):1015-1027.
    View in: PubMed
    Score: 0.231
  7. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
    View in: PubMed
    Score: 0.225
  8. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
    View in: PubMed
    Score: 0.223
  9. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2020 11; 95(11):2343-2349.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.